Baraliakos X, et al. Long-Term Evaluation of Secukinumab in Ankylosing Spondylitis: 5 Year Efficacy and Safety Results from a Phase 3 Trial. ACR 2018, abstract L13.
Behandelrespons en retentie na starten met TNF-remmer bij axSpA
sep 2019 | Spondyloartritis